Rating History for Akebia Therapeutics (AKBA) by WestPark Capital

More Stocks Rated by WestPark Capital | Latest Ratings for AKBA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/8/2026 N/A New Coverage Buy
(N/A)		 4.50
(N/A)		 0.97
(0.94)		 -3.09% Details